Drug Profile
Research programme: Alzheimer's disease therapies - Siena Biotech
Alternative Names: SEN 12333; SEN 34625; WAY-317538; WYE-103914Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Siena Biotech
- Class Small molecules
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease